Results 171 to 180 of about 7,297 (209)
Some of the next articles are maybe not open access.
Natural history of thyroid associated ophthalmopathy
Clinical Endocrinology, 1995SummaryBACKGROUND The natural history of thyroid associated ophthalmopathy is poorly documented, although It is widely thought that many cases Improve spontaneously with time. This has Important Implications in the management of patients and is also a critical factor when assessing the effects of different treatments.OBJECTIVE To document the natural
P, Perros +2 more
openaire +2 more sources
Choroidal vascularity index in thyroid-associated ophthalmopathy
Canadian Journal of Ophthalmology, 2023To investigate the choroidal vascularity index (CVI) in patients with thyroid-associated ophthalmopathy (TAO) and its relationship with clinical features and clinical activity score METHODS: Right eyes of 53 patients with TAO and 53 healthy subjects were scanned for subfoveal choroidal thickness (SFCT), CVI, choroid-stromal area (C-SA), choroid-luminal
Volkan Yeter +3 more
openaire +2 more sources
Medical Treatment for Thyroid-Associated Ophthalmopathy
Thyroid, 2002The medical management of thyroid-associated ophthalmopathy has been, and remains a clinical challenge. Several drugs have been used. Systemic steroids seem to be beneficial in patients with active disease. The evidence for the remaining drugs reported to be potentially useful, is unconvincing.
Petros, Perros, Pat, Kendall-Taylor
openaire +3 more sources
Octreoscan in Thyroid-Associated Ophthalmopathy
Thyroid, 2002Until recently, there was no imaging technique available that could be considered as a reliable measure of inflammation in thyroid-associated opthalmopathy (TAO). Pentetreotide (a synthetic derivative of somatostatin) labeled with 111In has been used to visualize somatostatin receptors in endocrine-related tumours in vivo.
openaire +2 more sources
The pathophysiology of thyroid-associated ophthalmopathy
Ophthalmology Clinics of North America, 2002TAO is an inflammatory disease of the orbital tissues. The effects of inflammation, mediated through cytokine release, include proliferation of fibroblasts, increased deposition of extracellular matrix, and adipocyte differentiation and proliferation. As a result, edema, enlargement of the extraocular muscles, and increased volume of the orbital soft ...
Mark P, Hatton, Peter A D, Rubin
openaire +2 more sources
Sinusitis in Thyroid Associated Ophthalmopathy
American Journal of Rhinology, 1993In 19 patients with thyroid associated ophthalmopathy undergoing orbital decompression, histologic examination of paranasal sinus mucosa revealed moderate to severe inflammatory alterations in all patients. Only 2/19 patients had a history of chronic sinusitis. In 4/19 patients, mucosal abnormalities of the paranasal sinuses were found on preoperative
S. Davris +3 more
openaire +1 more source
Radioiodine and thyroid-associated ophthalmopathy
Orbit, 1996Particular attention has recently been paid to the relationship between radioiodine administration and the course of thyroid-associated ophthalmopathy (TAO). Conflicting results have been reported in the literature, and radioiodine therapy has been associated either with aggravation, improvement, or no relevant changes of eye disease.
Claudio Marcocci +7 more
openaire +1 more source
Animal Models of Thyroid-Associated Ophthalmopathy
Thyroid, 2002Thyroid-associated ophthalmopathy (TAO) is an autoimmune condition most frequently associated with Graves' disease (GD). The thyrotropin receptor (TSHR) is an important target of the autoimmune response in both disorders. The last 5 years have seen some progress in the development of animal models, induced with TSHR preparations and reproducing some or
openaire +2 more sources
Progress in Thyroid-Associated Ophthalmopathy
Thyroid, 2002185 AN INTERNATIONAL SYMPOSIUM on progress in thyroid-associated ophthalmopathy (TAO) was held as a satellite to the 12th International Thyroid Congress, in Kyoto. The program addressed basic research and clinical management aspects of TAO. The symposium comprised 19 invited lectures and a poster session.
Yuji Hiromatsu, Jack R. Wall
openaire +1 more source
Thyroid-associated ophthalmopathy: pathogenesis and clinical management
Baillière's Clinical Endocrinology and Metabolism, 1995The pathogenesis of thyroid-associated ophthalmopathy is autoimmune. The questions to which answers are eagerly awaited are the identification of the autoantigen(s) and the definition of the autoimmune processes (cellular or humoral) responsible. Cellular and humoral immune responses and modulation by cytokines, against orbital tissues have been ...
P, Perros, P, Kendall-Taylor
openaire +2 more sources